The current epidemic of opioid misuse, opioid use disorder (OUD), and opioid-related overdose remains a growing public health crisis. In support of efforts by the U.S Food and Drug Administration (FDA) to reduce the impact of opioid misuse on public health, this public workshop will examine interventions and tools being utilized by policymakers, healthcare providers, health systems, payers, and pharmacy benefit managers to ensure the safe and appropriate prescribing of opioids These approaches may include prescribing guidelines, utilization of Prescription Drug Monitoring Programs (PDMPs), screening and risk-assessment tools, and other health system and payer strategies to manage opioid access and improve patient safety.
Through a cooperative agreement with the FDA, the Duke-Margolis Center will host a public workshop on February 15, 2018 to:
- Examine the landscape of health system and payer interventions to promote safe and appropriate prescribing of opioids.
- Discuss how health systems and payers are using data and health IT tools to support interventions.
- Discuss how health system approaches were implemented, barriers to their adoption, and potential unintended consequences of adoption.
- Discuss how to build an evidence base to support existing health system and payer interventions as well as how success may be defined and measured.
While this project is supported through a cooperative agreement with FDA, the views expressed in the accompanying documents are those of the participants in attendance, and do not necessarily reflect the official positions and policies of the Department of Health and Human Services, or imply endorsements by the U.S. Government or other organizations.